Evidence map›Paper›PMID 36605676›Full record

ReviewRSC advances2022

Effects of morphology and size of nanoscale drug carriers on cellular uptake and internalization process: a review.

Wenjie Zhang, Reza Taheri-Ledari, Fatemeh Ganjali, Seyedeh Shadi Mirmohammadi, Fateme Sadat Qazi, Mahdi Saeidirad, Amir KashtiAray, Simindokht Zarei-Shokat, Ye Tian, Ali Maleki

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 158 citations in OpenAlex.

  1. Review
  2. Article
  3. Nitrogen-Doped Carbon Dot/TiOBiomolecules · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. How Key in vivo Models Can Advance Anticancer Nanotherapeutics.International journal of nanomedicine · 2026
    Review
  17. Review
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Wenjie ZhangDepartment of Nuclear Medicine, West China Hospital, Sichuan University No. 37, Guoxue Alley Chengdu 610041 Sichuan Province P. R. China.
Reza Taheri-LedariCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.ORCID https://orcid.org/0000-0002-6511-9411
Fatemeh GanjaliCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.
Seyedeh Shadi MirmohammadiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.
Fateme Sadat QaziCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.
Mahdi SaeidiradCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.
Amir KashtiArayCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.
Simindokht Zarei-ShokatCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.
Ye TianDepartment of Orthodontics, West China Hospital of Stomatology, Sichuan University No. 14, 3rd Section of South Renmin Road Chengdu 610041 P. R. China.
Ali MalekiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran Rezataheri13661206@gmail.com R_taheri94@alumni.iust.ac.ir maleki@iust.ac.ir +98 21 73021584 +98 21 77240640-50.ORCID https://orcid.org/0000-0001-5490-3350
Iran University of Science and Technology · IRSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the field of targeted drug delivery, the effects of size and morphology of drug nanocarriers are of great importance and need to be discussed in depth. To be concise, among all the various shapes of nanocarriers, rods and tubes with a narrow cross-section are the most preferred shapes for the penetration of a cell membrane. In this regard, several studies have focused on methods to produce nanorods and nanotubes with controlled optimized size and aspect ratio (AR). Additionally, a non-spherical orientation could affect the cellular uptake process while a tangent angle of less than 45° is better at penetrating the membrane, and

Identifiers

PMID36605676
PMCPMC9764328
OpenAlexW4311964451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.